Takeda Pharmaceutical Company Limited
CYCLIC DINUCLEOTIDE

Abstract:

The present disclosure provides a compound having a STING agonistic activity, which may be expected to be useful as an agent for the prophylaxis or treatment of STING-related diseases. The present disclosure relates to a compound represented by the formula (I): ##STR00001## wherein each symbol is as defined in the description, or a salt thereof.